Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 530
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof >
Description:










Class Number Class Name No. of Patents
530/806

Antigenic peptides or proteins

675
530/800

Antihypertensive peptides

82
530/810

Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g., biological cell or cell fragment as carrier, etc.

261
530/811

Peptides or proteins is immobilized on, or in, an inorganic carrier

204
530/812

Peptides or proteins is immobilized on, or in, an organic carrier

285
530/813

Carrier is a saccharide

161
530/814

Cellulose or derivatives thereof

111
530/815

Carrier is a synthetic polymer

312
530/816

Attached to the carrier via a bridging agent

260
530/817

Entrapped within the carrier, e.g., gel, hollow fibre, etc.

71
530/802

Chromogenic or luminescent peptides

84
530/807

Hapten conjugated with peptide or protein

237
530/868

Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

258
530/862

Involving ige or igd

55
530/861

Involving igg3, igg4, iga, or igy

109
530/863

Involving igm

51
530/864

Monoclonal

119
530/865

Human

35
530/866

Involving immunoglobulin or antibody fragment, (e.g., f(ab)'2, fab', fab, fv, fc, heavy chain, light chain, etc.)

263
530/867

Involving immunoglobulin or antibody produced via recombinant dna technology

84
530/500

Lignins or derivatives

133
530/501

Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof

67
530/504

Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof

24
530/505

Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof

34
530/502

Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof

55
530/506

Heavy metal, aluminum, silicon or phosphorus containing

40
530/503

Hydrogenation of a lignin or lignin containing substance, or product thereof

6
530/507

Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof

44
530/808

Materials and products related to genetic engineering or hybrid or fused cell technology, e.g., hybridoma, monoclonal products, etc.

313
530/809

Fused cells, e.g., hybridoma, etc.

283
530/200

Natural resins or derivatives (e.g., wood or pine tar; cativo resin derivatives, etc.)

34
530/202

Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material)

12
530/203

Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material)

11
530/204

Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material)

10
530/205

Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.)

45
530/207

Esterification used in the process, or product thereof

10
530/208

Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.)

33
530/209

Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof

11
530/206

Organic sulfur or nitrogen containing material used in the process, or product thereof

15
530/210

Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.)

60
530/213

Boron or phosphorus containing material used in the process, or product thereof

23
530/214

Diels-alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.)

43
530/215

Esterification of rosin or derivative via carboxyl group, or product thereof

45
530/216

Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.)

25
530/217

Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.)

28
530/218

Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.)

53
530/226

Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.)

12
530/227

Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.)

11
530/223

Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.)

12
530/224

Metal containing material used to form salts of rosin acids, or product thereof

13
530/225

Alkali metal containing material (i.e., li, na, k, rb or cs)

8
530/221

Nitrogen containing material used in the process, or product thereof

32
530/222

The nitrogen containing material is inorganic

4
530/211

Polymerization or product thereof (e.g., dimer rosin, etc.)

40
530/212

Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.)

31
530/228

Purification process or product thereof

8
530/229

Immiscible solvents used in the process, or product thereof

2
530/219

Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.)

17
530/220

The sulfur, selenium, or tellurium containing material is inorganic

10
530/201

Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.)

11
530/230

Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.)

50
530/232

Esterification of tall oil acids, or product thereof

30
530/231

Nitrogen containing material used in the process, or product thereof

19
530/233

Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof

17
530/801

Peptide sweetners

58
530/300

Peptides of 3 to 100 amino acid residues

6767
530/327

11 to 14 amino acid residues in defined sequence

2339
530/326

15 to 23 amino acid residues in defined sequence

2924
530/325

24 amino acid residues in defined sequence

1158
530/324

25 or more amino acid residues in defined sequence

4374
530/330

4 to 5 amino acid residues in defined sequence

1985
530/329

6 to 7 amino acid residues in defined sequence

1859
530/328

8 to 10 amino acid residues in defined sequence

2626
530/316

Angiotensin; related peptides

69
530/314

Bradykinin; kallidin; related peptides

73
530/307

Calcitonin; related peptides

195
530/345

Chemical aftertreatment, e.g., acylation, methylation, etc.

1010
530/332

Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.

342
530/306

Corticotropin (atch); related peptides

62
530/317

Cyclic peptides

1420
530/320

Bacitracin; related peptides

37
530/321

Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides

223
530/318

The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid

50
530/319

Polymyxin; related peptides

31
530/302

Endorphin and enkephalin; related peptides

184
530/308

Glucagon; related peptides

226
530/310

Gramicidin or tyrocidin; related peptides

9
530/303

Insulin; related peptides

557
530/305

Isolation or purification

101
530/304

Metal complexes, e.g., zn-insulin, etc.

104
530/313

Lutenizing hormone releasing factor (lrf); related peptides

277
530/312

Melanotropin (msh) or eledoisin; related peptides

43
530/315

Oxytocin; vasopressin; related peptides

101
530/322

Peptides containing saccharide radicals, e.g., bleomycins, etc.

574
530/323

Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc.

458
530/309

Secretin or gastrin; related peptides

51
530/344

Separation or purification

527
530/311

Somatostatin (srif); related peptides

287
530/333

Synthesis of peptides

904
530/343

By hydrolysis

86
530/334

Polymer supported synthesis, e.g., solid phase synthesis, merrifield synthesis, etc.

633
530/335

Protecting or removing protective groups, e.g., carboxyl group protection, etc.

256
530/337

Of amino group

157
530/336

Of side chain or sulfur containing group

139
530/338

Solution phase synthesis

206
530/342

Mixed anhydride synthesis

26
530/339

Segment condensation, e.g., ugi condensation, etc.

83
530/340

With phosphorus containing material

32
530/341

With use of carbonimide or imidiazole

27
530/301

Thymopoietin or lipotropin; related peptides

44
530/331

Tripeptides, e.g., tripeptide thyroliberin (trh), melanostatin (mif), etc.

1616
530/855

Proteins from animals other than mammals or birds

67
530/857

Fish; fish eggs; shell fish; crustacea

88
530/858

Insects; venom

83
530/856

Snakes; venom

36
530/827

Proteins from mammals or birds

134
530/829

Blood

248
530/830

Plasma; serum

354
530/831

Cohn fractions

86
530/840

Bones; tendons; teeth; cartilage

117
530/828

Cancer

267
530/843

Digestive system

10
530/847

Bile

1
530/846

Liver

27
530/845

Pancreas

17
530/844

Stomach; intestine

15
530/849

Eyes; vessels; umbilical cord

12
530/854

Glands

49
530/848

Lungs

25
530/837

Lymph; lymph-glands; thymus

46
530/838

Marrow; spleen

32
530/832

Milk; colostrum

99
530/836

Mucus; mucous glands; bursa; arthral fluid; spinal fluid

9
530/841

Muscles; heart

42
530/839

Nerves; brain

81
530/850

Reproductive organs or embryos

49
530/851

Placenta; amniotic fluid

83
530/852

Sperm

24
530/853

Ovary; eggs; embryos

59
530/842

Skin; hair; nails; sebaceous glands; cerumen

43
530/834

Urine; urinary system

49
530/835

Kidney

23
530/833

Whey; cheese

95
530/820

Proteins from micro-organisms

162
530/825

Bacteria

614
530/823

Lower fungi, e.g., mold, etc.

41
530/824

Yeasts

78
530/822

Protozoa

66
530/821

Separation of nucleic acid

35
530/826

Viruses

282
530/350

Proteins, i.e., more than 100 amino acid residues

17329
530/362

Albumin

271
530/365

Lactalbumin, e.g., milk source, etc.

64
530/366

Separation, purification or synthesis

68
530/367

Ovalalbumin, e.g., avidin, conalbumins, etc.

80
530/368

Separation, purification or synthesis

20
530/369

Separation, purification or synthesis

34
530/363

Serum albumin, e.g., bsa, hsa, etc.

488
530/364

Separation, purification or synthesis

174
530/380

Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.

1081
530/381

Blood coagulation factors and fibrin, e.g., thromboplastin, etc.

527
530/384

Blood coagulation factor ii or factor ii + vii + ix + x, i.e., prothrombin complex or factor

314
530/383

Blood coagulation factor viii, ahf

450
530/382

Fibrin or fibrin intermediates, e.g., fibrinogen, etc.

315
530/386

Globulins

259
530/392

Alpha globulins, e.g., ceruloplastin, haptoglobins, etc.

97
530/393

Antithrombin iii

61
530/394

Beta globulins, e.g., transferrin, etc.

100
530/387.1

Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed

4495
530/387.2

Anti-idiotypic

225
530/387.7

Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)

808
530/387.5

Binds oligosaccharide structure

216
530/387.9

Binds specifically-identified amino acid sequence

1985
530/387.3

Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rfv, immunoglobulin fusion protein, etc.)

3235
530/388.1

Monoclonal

3265
530/388.9

Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

318
530/388.2

Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)

1070
530/388.4

Binds bacterium or similar microorganism or component or product thereof (e.g., stretococcus, legionella, mycoplasma, bacterium-associated antigen, exotoxin, etc.)

356
530/388.8

Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

977
530/388.85

Binds antigen characterized by name or molecular weight (e.g., cea, nca, cc glycoprotein, melanoma gp 150 antigen, etc.)

817
530/388.26

Binds enzyme

397
530/388.5

Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.)

78
530/388.7

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)

578
530/388.73

Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., b cell, b-lineage bone marrow cell, null cell, natural killer cell, b-lymphoblastoid cell, b-lineage acute lymphoblastic leukemia cell, b-lymphocytic cell-surface antigen, etc.)

467
530/388.75

Binds t-lymphocytic cell or component or product thereof (e.g., t cell, thymocyte, t-lineage bone marrow cell, t-lymphoblastoid cell, t-lineage acute lymphoblastic leukemia cell, t-lymphocytic cell-surface antigen, etc.)

445
530/388.24

Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)

561
530/388.23

Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)

833
530/388.21

Binds nucleic acid or derivative or component thereof (e.g., dna, rna, dna-rna hybrid, nucleotide, nucleoside, carcinogen-dna adduct, etc.)

73
530/388.6

Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., dirofilaria, eimeria, coccidia, trichinella, parasite cell-surface antigen, etc.)

118
530/388.25

Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

520
530/388.22

Binds receptor (e.g., transferrin receptor, fc receptor, dihydropyridine receptor, il-2 receptor, etc.)

1593
530/388.3

Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

338
530/388.35

Binds retrovirus or component or product thereof (e.g., hiv, lav, htlv, etc.)

188
530/388.15

Human

956
530/389.1

Polyclonal antibody or immunogloblin of identified binding specificity

1157
530/389.5

Binds bacterium or similar microorganism or component or product thereof (e.g., pseudomonas, chlamydia, clostridium, bacterium-associated antigen, etc.)

227
530/389.7

Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

398
530/389.8

Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

386
530/389.6

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.)

236
530/389.2

Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)

556
530/389.3

Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

291
530/389.4

Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

237
530/390.1

Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)

120
530/390.5

Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)

161
530/391.1

Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.)

1154
530/391.7

Conjugated to a cytotoxic agent, drug, or other biologically-active substance

877
530/391.9

Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent

344
530/391.3

Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound

1296
530/391.5

Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent

426
530/385

Hemoglobins or globins

450
530/360

Casein or caseinate

142
530/361

Separation, purification or synthesis

79
530/402

Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.

2114
530/407

Hydrolysis of protein

146
530/409

Nitrogen containing reactant

544
530/410

Oxygen containing reactant

351
530/411

Oxygen containing is saccharide

86
530/403

Protein is identified as an antigen, e.g., immunogenic carriers, etc.

922
530/405

Nitrogen containing reactant

606
530/406

Oxygen containing reactant

290
530/404

Sulfur containing reactant

331
530/408

Sulfur containing reactant

393
530/395

Glycoprotein, e.g., mucins proteoglycans, etc.

1776
530/397

Glycoprotein hormones

367
530/398

Gonadatropins

155
530/396

Lectins, e.g., concanavalin, hemagglutinin, etc.

150
530/399

Hormones, e.g., prolactin, thymosin, growth factors, etc.

2051
530/359

Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.

210
530/351

Lymphokines, e.g., interferons, interlukins, etc.

2658
530/400

Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.

210
530/401

Cytochromes, e.g., chlorophyl, orgotein, etc.

39
530/358

Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc.

245
530/352

Phosphoproteins, e.g., phosvitin, vitellogenin, etc.

145
530/370

Plant proteins, e.g., derived from legumes, algae or lichens, etc.

1083
530/371

Derived from fungi, e.g., yeasts, mushroom, etc.

133
530/372

Derived from grain, e.g., prolamines, etc.

116
530/376

Derived from corn

76
530/375

Derived from wheat

80
530/374

Gluten or gliadin

83
530/373

Zein

36
530/379

Derived from leafy green plants, e.g., alfalfa pollen, etc.

135
530/377

Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.

192
530/378

Derived from soybean

251
530/353

Scleroproteins, e.g., fibroin, elastin, silk, etc.

165
530/356

Collagen

632
530/354

Gelatin

246
530/355

Separation, purification or synthesis

100
530/357

Keratin

100
530/412

Separation or purification

1648
530/413

Immunological separation or affinity chromatography

1260
530/427

Physical treatment

344
530/418

Precipitation

307
530/419

With added material

235
530/420

Inorganic

207
530/421

Polymeric, e.g., polyethylene glycol, etc.

145
530/415

Selective absorbtion, e.g., ca phosphate sorbents, etc.

384
530/417

Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.

834
530/416

Ion exchange

708
530/422

Solvent extraction

232
530/426

Hydrocarbon or halogenated hydrocarbon

28
530/423

Oxygenated material

69
530/424

Alcohol

92
530/425

Carboxyl containing

40
530/414

Ultra filtration or osmosis

304
530/860

Renin inhibitors

135
530/859

Waste, waste material, refuse or sludge, e.g., effluents, fecal matter, etc.

41
 
 
  Recently Added Patents
Web development environment that enables a developer to interact with run-time output presentation of a page
Triple-trim reference voltage generator
Compounds for nonsense suppression and methods for their use
Semiconductor device and method of manufacturing the same
Editing device and editing method
Processing color and panchromatic pixels
System and method for efficient association of a power outlet and device
  Randomly Featured Patents
Dispensing device
Optical amplifier with low crosstalk and component including this amplifier
Infinitely variable transmission
Gas exchange system flow configuration
Magnetic transducer head having series connected magnetroresistance effect sensing element with head output connected between the sensing elements
Removable hinge at specific angular orientation
Method for encasing waste barrels in a leachproof closed sheath
Calendar electronic timepiece
Low lag luminescent phosphors and X-ray screen containing the same
Graphical manipulation in a mobile wireless device